Dalian Lansen Detai Biopharmaceutical Co., Ltd.

Dalian, China

Overview

Dalian Lansen Detai Biopharmaceutical Co., Ltd. is a leading biopharmaceutical company based in China, specializing in the development of innovative therapeutics for a wide range of medical conditions. The company is known for its strong focus on research and development, aiming to deliver advanced healthcare solutions.

Therapeutic areas

OncologyCardiovascularImmunology

API / Drug Master Files

Dalian Lansen Detai Biopharmaceutical Co., Ltd. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • EXOSOMEActive2026-03-08

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Dalian Lansen Detai Biopharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Chemexpress Co., Ltd.
China
Tasly Pharmaceutical Group Co., Ltd.
China
Xiamen Mogengel Biotechnology Co., Ltd.
China
Yantai Rongchang Pharmaceutical Co., Ltd.
China
Zhejiang Hisun Pharmaceutical Co., Ltd.
China
24cedo S.A.
Argentina
3BMS Australia Pty Ltd
Australia
Angitia Biopharmaceuticals, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo